Guo Xuan-Yan, Xiong Mao-Xiang, Zhao Yu, He Fan-Ding, Cheng Xue-Qing, Wu Yan-Yan, Chen Kai, Lu Man
Ultrasonic Department, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China.
Eur Neurol. 2017;78(1-2):33-40. doi: 10.1159/000477719. Epub 2017 Jun 7.
To compare the clinical effectiveness of ultrasound-guided corticosteroid injection with and without needle release of the transverse carpal ligament (TCL) in carpal tunnel syndrome (CTS).
Between May 2014 and June 2016, 52 patients (56 wrists) with CTS were included in this study. Among these patients, 28 wrists were treated with ultrasound-guided corticosteroid injection plus needle release of the TCL (group A) and 28 wrists were treated with a single ultrasound-guided corticosteroids injection (group B). The following parameters were assessed and compared including postoperative results of procedure based on relief of symptoms, electrophysiological parameters (distal motor latency, sensory conduction velocity, and sensory nerve action potential of median nerve), and ultrasound parameters (anteroposterior diameter and cross-sectional area of the median nerve at the levels of pisiform and hamate bone, and the thicknesses of TCL on the cross-section at the level of hamate bone).
The overall excellent and good rate regarding the postoperative results of procedure based on the relief of symptoms at 1 month postoperatively was 82.1% in group A and 46.4% in group B (p = 0.004). There was significant difference in the above electrophysiological and ultrasound parameters between the preoperative and postoperative values in both groups (all p < 0.05). Furthermore, a significant difference was also observed in the postoperative values of the above-mentioned electrophysiological and ultrasound parameters in the 2 groups (all p < 0.05).
Both approaches had treatment benefit in CTS. Ultrasound-guided corticosteroid injection in combination with needle release of the TCL is superior to the single ultrasound-guided corticosteroids injection.
比较超声引导下皮质类固醇注射联合或不联合腕横韧带(TCL)针刀松解治疗腕管综合征(CTS)的临床疗效。
2014年5月至2016年6月,本研究纳入52例(56腕)CTS患者。其中,28腕接受超声引导下皮质类固醇注射联合TCL针刀松解治疗(A组),28腕接受单纯超声引导下皮质类固醇注射治疗(B组)。评估并比较以下参数,包括基于症状缓解的术后手术结果、电生理参数(正中神经的远端运动潜伏期、感觉传导速度和感觉神经动作电位)以及超声参数(豌豆骨和钩骨水平正中神经的前后径和横截面积,以及钩骨水平横断面上TCL的厚度)。
术后1个月基于症状缓解的手术总体优良率,A组为82.1%,B组为46.4%(p = 0.004)。两组术前和术后上述电生理和超声参数均有显著差异(均p < 0.05)。此外,两组上述电生理和超声参数的术后值也有显著差异(均p < 0.05)。
两种方法对CTS均有治疗益处。超声引导下皮质类固醇注射联合TCL针刀松解优于单纯超声引导下皮质类固醇注射。